BioMagnetic Solutions

We are driven by our years of experience in innovative product development and partnering across the biopharma and life sciences tools industry. Our state-of-the-art platforms offer clinicians, biomedical scientists, and researchers an alternative to existing immunomagnetic cell separation systems. New office and laboratory space and cGMP-grade production facility will be completed later in 2022 to support these efforts. BioMagnetic Solutions provides clinicians, researchers, and cell & gene therapy manufacturers with state-of-the-art technologies for improving immunomagnetic cell separation workflows. BioMagnetic Solutions aspires to create, develop, and commercialize, class-leading cGMP ferrofluid based cell selection technologies. These technologies easily integrate into existing cellular manufacturing workflows, out-perform competitive technologies, and create over-performing value for our customers.